BioMarin Pharmaceutical, Inc. (BMRN)

54.64 +0.54 (+1.00%) USD  |  NASDAQ  |  Apr 17, 16:00
54.67 +0.03 (+0.05%) After-Hours: 20:00
More

BioMarin Pharmaceutical SG&A Expense (Quarterly) : 446.21M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. 117.08M
Ionis Pharmaceuticals, Inc. 130.00M
Mirum Pharmaceuticals, Inc. 74.13M
Hims & Hers Health, Inc. 314.21M
ACADIA Pharmaceuticals, Inc. 155.62M